Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EntryPoint Capital
New York, New York, United States
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
EntryPoint Capital is a private investment management firm based in New York that describes itself as a systematic quantitative investment manager. Available public descriptions indicate that the firm has a healthcare-focused strategy and invests in public-market companies, including biotechnology and other healthcare businesses, rather than developing drugs or medical products itself. The firm appears to be active as an SEC-reporting institutional investment manager with recent 13F filings. Because it is an asset manager rather than a therapeutics developer, it does not appear to have a clinical pipeline, therapeutic targets, or product-stage programs of its own.
- Industry
- Investors
Beyond the preview
Go deeper on EntryPoint Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EntryPoint Capital.